Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2018/06/014444
CTRI/2018/06/014444
Completed
Phase 4

A Prospective study to evaluate the Safety and Efficacy of Investigational Anti-Hair fall shampoo in comparison with Comparator Anti-Hair fall shampoo in subjects with very less to severe Hair fall

Dhathri Ayurveda Pvt Ltd0 sites40 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Dhathri Ayurveda Pvt Ltd
Enrollment
40
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
July 10, 2018
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dhathri Ayurveda Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • •Willingness to give written informed consent
  • •Subjects in the range of 18\-50 years of age
  • •Subjects with very less to severe Hair fall.
  • •Willingness to discontinue any hair care product other than the IP throughout the study.
  • •Subjects who are not willing to color their hair throughout the treatment period
  • •Subjects willing to stop all the hair treatment such as hair spa, straightening, curling, perming, etc.
  • •Subjects with no skin allergies to any cosmetic products
  • •Willingness to follow the protocol requirements as evidenced by written informed consent
  • •Comprehension of the nature and purpose of the study and compliance with the requirement of the entire procedure
  • •In addition, female subjects selected for the study must be able to use a medically acceptable form of birth control during the study or be surgically sterile or be post\-menopausal for at least 1 year.

Exclusion Criteria

  • •1\. Subjects with known hypersensitivity to any specific
  • •ingredients of IPs
  • •2\. Subjects below the age of 18 years and subjects above 50
  • •3\. Subjects not willing to participate in the study
  • •4\. Subjects who have previously undergone hair transplantation
  • •5\. Subjects with any skin diseases.
  • •6\. Subjects are being treated for hair fall or severe active
  • •infection of any type previously
  • •7\. Presence of any underlying significant uncontrolled medical
  • •illness involving the cardiovascular, respiratory, renal,

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 4
To study the Safety and Efficacy of Investigational Hair oil in comparison with coconut oil and comparator Hair oil in subjects with mild to severe Hair fall
CTRI/2020/04/024824Thai Herbals
Completed
Phase 4
Study to evaluate the Safety and Efficacy of Investigational Hair Oil in comparison with Coconut oil and Comparator Hair Oil in subjects with mild to severe Hair fall.
CTRI/2018/05/014260Dhathri Ayurveda Pvt Ltd40
Completed
Phase 4
To evaluate the Safety and Efficacy of Investigational Hair creme in comparison with coconut oil in subjects with mild to severe Hair fall
CTRI/2018/06/014418Dhathri Ayurveda Pvt Ltd40
Completed
Not Applicable
Study to Evaluate the Safety and Efficacy of Levetiracetam in Comparison To Magnesium Sulphate in the Management of Severe Pre â?? Eclampsia
CTRI/2020/02/023194BLDE Deemed to be University30
Active, not recruiting
Phase 1
A study evaluating the effect of EVARREST® Fibrin Sealant Patch as an adjunct to haemostasis in controlling mild to moderate bleeding during open surgery in paediatric patientsMild or moderate hepatic parenchyma or soft tissue bleeding duringopen, abdominal, retroperitoneal, pelvic and thoracic (non-cardiac) surgeryTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]
EUCTR2019-004657-89-GBEthicon Inc35